Open AccessEnhanced Cardiac Testing in a Dual Anti‐HER2 Regimen: What Have We Learned?
Author(s) -
Ewer Michael S.,
Swain Sandra M.
Publication year - 2016
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2016-0069
Subject(s) - medicine , cardiotoxicity , dexrazoxane , trastuzumab , anthracycline , cardioprotection , oncology , doxorubicin , regimen , pharmacology , adverse effect , clinical trial , cardiology , chemotherapy , cancer , myocardial infarction , breast cancer